IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 42 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,453,000 | – | 252,160 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 860,500 | $3,588,000 | 1.79% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 694,363 | $2,895,000 | 0.90% |
| MARATHON ASSET MANAGEMENT LP | 792,434 | $3,305,000 | 0.36% |
| CORRADO ADVISORS, LLC | 119,922 | $500,000 | 0.29% |
| BARD ASSOCIATES INC | 305,500 | $1,275,000 | 0.12% |
| Granite Investment Partners, LLC | 297,297 | $1,239,000 | 0.08% |
| WEALTHSOURCE PARTNERS, LLC | 30,000 | $125,000 | 0.05% |
| Apollo Management Holdings, L.P. | 100,000 | $417,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 10,000 | $42,000 | 0.01% |
| Virtu KCG Holdings LLC | 31,222 | $130,000 | 0.00% |